Incyte Corp. (INCY)
95.34
-1.76
(-1.81%)
USD |
NASDAQ |
Apr 16, 16:00
95.34
0.00 (0.00%)
After-Hours: 18:15
Incyte Market Cap : 18.97B for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 807.26B |
| ACADIA Pharmaceuticals, Inc. | 3.625B |
| Merck & Co., Inc. | 285.44B |
| Madrigal Pharmaceuticals, Inc. | 12.04B |
| Alnylam Pharmaceuticals, Inc. | 42.45B |
Market Cap Related Metrics
| PE Ratio | 14.89 |
| PS Ratio | 3.723 |
| PEG Ratio | 0.0066 |
| Price to Book Value | 3.672 |
| Price to Free Cash Flow | 14.40 |
| Price | 95.34 |
| Earnings Yield | 6.72% |
| PEGY Ratio | 0.0066 |
| Operating PE Ratio | 14.26 |
| Normalized PE Ratio | 16.49 |